Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ms-553 (2 trials)
Diabetes Mellitus (Phase 1)
Diabetic Retinopathy (Phase 1)
Edema (Phase 1)
Macular Edema (Phase 1)
Retinal Diseases (Phase 1)
Trials (2 total)
Trial APIs (1 total)